The prevalence of obesity and diabetes has grown worldwide, presenting notable challenges to public health and health care ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

The administration is reviewing a Centers for Medicare and Medicaid Services rule that would expand coverage to Medicare and Medicaid recipients ...

The Canadian Medical Association and the World Health Organization (WHO) consider obesity as a progressive chronic disease ...

The Department of Social Services remains committed to exploring policy solutions that maximize health outcomes while maintaining fiscal sustainability ...

Obesity prevalence increased among both adults and children across all regions of the world from 1990 to 2021, and more than ...

Rates of obesity and overweight are spiralling due to a "monumental societal failure" to tackle the problem, with more than ...

But the largest driver was the popularity of the expensive GLP-1 drugs used to treat diabetes and obesity. Costs for five of those drugs — Ozempic, Mounjaro, Wegovy, Zepbound, and Saxenda ...

Data from 2019 show India's obesity cost at $28.95 billion, projected to reach $81.53 billion by 2030 without intervention. Recommendations include implementing a 'fat tax' and promoting physical ...

The state’s cap-and-trade program is under scrutiny for how much it charges businesses for releasing pollution. The so-called social cost of carbon is triggering a debate in California over ...

PM Modi's concern over India's rising obesity is justified, as data reveals a significant economic impact. The cost of obesity in India stood at $28.95 billion in 2019 and is projected to reach $ ...

As the battle against obesity and diabetes heats up ... Price tag and prescription – Mounjaro Costs. Mounjaro isn’t cheap. With prices between €100 and €300, the long-term maintenance comes to around ...